Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 23 tulemused
Treatment of non-inflammatory and non-infectious bowel disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
This invention relates to the production and use of therapeutic agents for the treatment of certain bowel disorders, namely disorders arising from unknown or non-obvious causes, which are unaccompanied by inflammation and are not due to detectable infection by known pathogenic
Compounds as delta opioid agonists
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This application claims priority from U.K. application serial no. 9804734.3 which was filed on Mar. 5, 1998.
The present invention relates to compounds, including inter alia pharmaceutical compositions comprising the same and methods for making the same.
In particular, the present invention relates
Salts of trimebutine and N-desmethyl trimebutine
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
The present invention relates to unique salts of trimebutine and N-monodesmethyl trimebutine, and their corresponding stereoisomers, having improved analgesic properties useful in the treatment of visceral pain in general and more particularly in the treatment of conditions
Synthetic lactone formulations and methods of use
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present inventions are generally in the fields of pharmaceutically active lactones, their pharmaceutical formulations, and method of use thereof, and methods for the synthetic preparation of chemically functionalized lactones useful therefor as anticancer, antiinfective
Synthetic lactone formulations and method of use
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present inventions are generally in the fields of pharmaceutically active lactones, their pharmaceutical formulations, and method of use thereof, and methods for the synthetic preparation of chemically functionalized lactones useful therefor as anticancer, antiinfective and anti-inflammatory
GABA analogs to prevent and treat gastrointestinal damage
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to a method for preventing visceral and gastrointestinal damage such as gastric ulcers by administering a gamma-aminobutyric acid (GABA) analog, and for treating gastrointestinal diseases such as inflammatory bowel disorders (IBD), functional bowel
Methods of preventing and reducing the severity of stress-associated conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to the sympathetic nervous system and various stress-associated conditions and, in particular, to the .alpha.-2 adrenergic agonist, brimonidine.
2. Background Information
Conditions that are associated with or
Medicine for the treatment of illnesses of the respiratory organs
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to the use of gallic acids chenodeoxycholic acid and ursodeoxycholic acid or a combination thereof for the manufacture of a medicine.
The chemical designation of chenodeoxycholic acid is 3.alpha.,7.alpha.-Dihydroxy-5.beta.-cholan-24-oic-acid. The
Diagnosis and treatment of a disorder of the gastrointestinal tract
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention relates to the therapy of irritable bowel syndrome (IBS), in particular, upper irritable bowel syndrome (non-ulcerative dyspepsia), and related conditions as hereinafter described.
Irritable bowel syndrome is the most common reason for referral to
Diagnosis and treatment of a disorder of the gastrointestinal tract
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
This invention relates to the therapy of irritable bowel syndrome (IBS), in particular, upper irritable bowel syndrome (non-ulcerative dyspepsia), and related conditions as hereinafter described.
Irritable bowel syndrome is the most common reason for referral to
Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to novel conformationally-defined macrocyclic compounds that bind to and/or are functional modulators of the motilin receptor including subtypes, isoforms and/or variants thereof. These macrocyclic compounds possess appropriate pharmacological
Treatments for gastrointestinal disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE LISTING
This application incorporates by reference in its entirety the Sequence Listing entitled "IW112PCT1US1a_ST25", containing 4.52 KB of data and last modified on May 11, 2016, in computer readable-format (CRF) and electronic .txt format, filed electronically herewith.
FIELD OF THE
Treatments for gastrointestinal disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to peptides, compositions and methods for treating gastrointestinal disorders.
SEQUENCE LISTING
This application incorporates by reference in its entirety the Sequence Listing entitled "IW087_seq_ST25.txt" (527 bytes), which was created Feb. 17, 2011 and
Methods and compositions for the treatment of gastrointestinal disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE LISTING
This application incorporates by reference in its entirety the Sequence Listing entitled "Sequence Listing 22003040.txt", containing 33 kilobytes of data, created Aug. 13, 2008, and filed with the parent application U.S. application Ser. No. 11/930,696 on Aug. 18, 2008 in computer
Methods and compositions for the treatment of gastrointestinal disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
This invention relates to methods and compositions for treating various disorders, including gastrointestinal disorders, obesity, congestive heart failure and benign prostatic hyperplasia.
BACKGROUND
Irritable bowel syndrome (IBS) is a common chronic disorder of the intestine that
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
